Green Thumb Industries GTBIF
OTC GTBIF
$7.67 +0.16 (+2.13%)
As of: Aug 21, 2026 · 3:59 PM EDT

Green Thumb Industries (GTBIF) Income from Continuing Operations (2019 - 2026)

Green Thumb Industries' (GTBIF) quarterly Income from Continuing Operations came in at 15047000.0 in Q1 2026, up 79.11% YoY from 8401000.0 in Q1 2025, and down 93.04% on a QoQ basis from 216267000.0 in Q4 2025.

Green Thumb Industries (GTBIF) Income from Continuing Operations (2019 - 2026) Analysis & Trends

Green Thumb Industries (GTBIF) has 8 years of Income from Continuing Operations data on file, last reported at 15047000.0 in Q1 2026.

  • Quarterly Income from Continuing Operations rose 79.11% year-over-year to 15047000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 255847000.0 (up 63.51% YoY) and the FY2025 annual result came in at 249201000.0, up 38.89% from the prior year.
  • Income from Continuing Operations retreated to 15047000.0 in Q1 2026, from 216267000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 216267000.0 in Q4 2025 to a low of 98994000.0 in Q4 2022.
  • A 5-year average of 31324647.06 and a median of 15047000.0 in 2026 frame the typical range for Income from Continuing Operations.
  • Annual changes were most pronounced in 2022 — Income from Continuing Operations plunged 166.62% — and 2024, when it surged 233.31%.
  • Tracing GTBIF's Income from Continuing Operations over 5 years: stood at 98994000.0 in 2022, then jumped by 190.29% to 89377000.0 in 2023, then surged by 32.44% to 118374000.0 in 2024, then surged by 82.7% to 216267000.0 in 2025, then plunged by 93.04% to 15047000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 15047000.0 (Q1 2026), 216267000.0 (Q4 2025), and 23801000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -576.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 866.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 1.33 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 333.00 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -118.80 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 144.40 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 54.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Green Thumb Industries 1.69 Bn 1.41 Bn 137.87 Mn 3.43 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.43 Mn
Mar 31, 2026 15.05 Mn
Dec 31, 2025 216.27 Mn
Sep 30, 2025 23.80 Mn
Jun 30, 2025 732,000.00
Mar 31, 2025 8.40 Mn
Dec 31, 2024 118.37 Mn
Sep 30, 2024 8.78 Mn
Jun 30, 2024 20.92 Mn
Mar 31, 2024 31.35 Mn
Dec 31, 2023 89.38 Mn
Sep 30, 2023 10.81 Mn
Jun 30, 2023 13.69 Mn
Mar 31, 2023 9.41 Mn
Dec 31, 2022 -98.99 Mn
Sep 30, 2022 10.15 Mn
Jun 30, 2022 24.73 Mn
Mar 31, 2022 29.69 Mn
Dec 31, 2021 148.61 Mn
Sep 30, 2021 21.59 Mn